OCULUS, Inc.
$204.0K 74 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Austin Medical Ventures Inc
Austin Medical Ventures Inc reported $204,609.94 across General Payments, Research, and Ownership to 11 physicians and teaching hospitals across 11 transactions.
- $204.6K Below-median payer
- All-tracks total
- 11 Below-median volume
- Transactions
- 11 Below-median reach
- Recipients
- +$71.8K
- General Payments vs PY2023
Austin Medical Ventures Inc reported $204,609.94 across all CMS Open Payments tracks (General + Research + Ownership) to 11 physicians and teaching hospitals in Program Year 2024 - ranking #993 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $204,609.94, averaging $18.6K per recipient.
Austin Medical Ventures Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
17/100
Total payments
F
12/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer austin-medical-ventures-inc Austin Medical Ventures Inc
$204.6K · #993/1,925 · 0.0% industry · PY2024
- TOT $204.6K
- RANK #993
- SHARE 0.0%
- TXN 11
- RCP 11
- CAT 3
- GEN $204.6K
- ΔGEN +$71.8K
- TOP1 50.5%
- PY 2024
Volume peers
Nearest volume peer: OCULUS, Inc. ($204.0K)
Austin Medical Ventures Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Austin Medical Ventures Inc's CMS-reported General Payments increased by $71.8K (+54.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: AUSTIN MEDICAL VENTURES INCPY2023: AUSTIN MEDICAL VENTURES INCPY2024: Austin Medical Ventures Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $132,776.18
- PY2024
- $204,609.94
What the Data Shows for Austin Medical Ventures Inc
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Austin Medical Ventures Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Royalty or License" at $202.5K, accounting for 98.9% of this company's General Payments and 8 transactions.
General Payment Breakdown by Type
Austin Medical Ventures Inc made 3 types of general payments. "Royalty or License" is the largest category at $202.5K, 98.9% of General Payments.
How Austin Medical Ventures Inc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $202.5K | 8 | 98.9% |
| Consulting Fee | $2.1K | 2 | 1.0% |
| Food and Beverage | $29.73 | 1 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $204,609.94 (100.0%) of $204,609.94 in this company's General Payments records across 5 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Austin Medical Ventures Inc
The five named recipients with the highest reported General Payments from this company
- 1
Andrew Wassef
$103,265.74 across 4 reported transactions
- 2
Edward Mcpherson
$99,184.47 across 4 reported transactions
- 3
Christopher Gauland
$1,680.00 across 1 reported transactions
- 4
Paul Matuszewski
$450.00 across 1 reported transactions
- 5
Scott Plaster
$29.73 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Austin Medical Ventures Inc ranks #993 of 1,925 by total payments (bottom 48% by spend) but is notably more concentrated than that alone would suggest -- #378 of 1,838 by HHI (top 21% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- 3D Systems : $2.5K total payments, HHI 4970
- Encision Inc : $7.1K total payments, HHI 4966
- ExThera Medical Corporation : $192.6K total payments, HHI 4943
- Itamar Medical Inc : $477.1K total payments, HHI 4917
- Elekta Limited : $1.3K total payments, HHI 4913
- Innova Vascular Inc. : $11.1K total payments, HHI 4911
- Austin Medical Ventures Inc (this company) : $204.6K total payments, HHI 4898
- Dentium USA : $63.0K total payments, HHI 4887
- Novavax Inc : $146.8K total payments, HHI 4878
- D.T. Davis Enterprises, Ltd : $36.4K total payments, HHI 4874
- Terumo BCT, Inc. : $78.4K total payments, HHI 4865
- ETS Wound Care LLC : $260.4K total payments, HHI 4864
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Austin Medical Ventures Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Austin Medical Ventures Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Austin Medical Ventures Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
TruAbutment Inc.
$204.0K 54 recipients
Compare payment profiles
ITF Therapeutics LLC
$205.4K 296 recipients
Compare payment profiles
Siesta Medical, Inc.
$203.7K 13 recipients
Compare payment profiles
Maquet Cardiopulmonary GmbH
$205.7K 14 recipients
Compare payment profiles
Polarean, Inc.
$206.6K 40 recipients
Compare payment profiles
Put this to use
Austin Medical Ventures Inc ranks #993 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Austin Medical Ventures Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.